Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib
| Class:Id | LiteratureReference:1181048 |
| _displayName | EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib |
| _timestamp | 2011-01-27 17:34:16 |
| author | [Person:1181043] Pao, W [Person:1181052] Miller, V [Person:1181050] Zakowski, M [Person:1181042] Doherty, J [Person:1181049] Politi, K [Person:1181040] Sarkaria, I [Person:1181041] Singh, B [Person:1181045] Heelan, R [Person:1181053] Rusch, V [Person:1181047] Fulton, L [Person:1181044] Mardis, E [Person:217267] Kupfer, D [Person:207744] Wilson, R [Person:1181051] Kris, M [Person:207898] Varmus, H |
| created | [InstanceEdit:1181046] Orlic-Milacic, Marija, 2011-01-27 |
| journal | Proc Natl Acad Sci U S A |
| pages | 13306-11 |
| pubMedIdentifier | 15329413 |
| title | EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib |
| volume | 101 |
| year | 2004 |
| (literatureReference) | [EntityWithAccessionedSequence:1173212] EGFR L858R [plasma membrane] [Homo sapiens] [CandidateSet:1182964] EGFR L747_A750del spanning mutants [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228012] EGFR L747_T751delinsP [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228015] EGFR L747_T751del [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228016] EGFR L747_S752del [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228031] EGFR E746_T751delinsA [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228037] p-6Y-EGFR E746_T751delinsA [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228040] p-6Y-EGFR L747_S752del [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228041] p-6Y-EGFR L747_T751del [plasma membrane] [Homo sapiens] [EntityWithAccessionedSequence:1228042] p-6Y-EGFR L747_T751delinsP [plasma membrane] [Homo sapiens] |
|
[Change default viewing format]
|
No pathways have been reviewed or authored by EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib (1181048)